Showing results (1-10 of 305) with videos related to

Sort By:
Pageof 31
Nouvelle Revue Francaise D'Hematologie|January 1, 1995
Peripheral blood progenitor cell transplantation in FranceJ Reiffers, C Faberes, M L Tanguy
Leukemia & Lymphoma|January 1, 1993
Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 casesJ Reiffers, M Montastruc, G Marit, et al.
Pathologie-Biologie|September 1, 1988
[Early septicemia episodes in 143 bone marrow grafts]G Marit, J Texier, J Reiffers
Journal of Hematotherapy|January 1, 1994
Peripheral blood progenitor cell transplantation in 118 patients with hematological malignancies: analysis of factors affecting the rate of engraftmentJ Reiffers, C Faberes, J M Boiron, et al.
Bone Marrow Transplantation|January 1, 1994
Autologous transplantation in chronic myelogenous leukemia: European results: Chronic Leukemia Working Party of the EBMTJ Reiffers, J Goldman, G Meloni, et al.
Bulletin Du Cancer|January 1, 1985
[Treatment of acute myeloid leukemia with amsacrine and high-dose cytosine arabinoside: a phase II trial]G Marit, B David, J Reiffers, et al.
Bone Marrow Transplantation|August 24, 1999
Autologous stem cell transplantation in chronic myeloid leukemia: a single center experienceA Pigneux, C Faberes, J M Boiron, et al.
Leukemia|September 16, 1998
Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric studyG Marit, F Thiessard, C Faberes, et al.
Bone Marrow Transplantation|July 1, 1995
Busulphan and melphalan prior to autologous transplantation for myeloid malignanciesP Cony-Makhoul, G Marit, J M Boiron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myelomaG Marit, C Faberes, J L Pico, et al.
Pageof 31